Dong-A Socio Holdings Co Ltd 2013 AR2
The report highlights Dong-A Socio Group's transition to a holding company structure in 2013, demerging into Dong-A Socio Holdings, Dong-A ST, and Dong-A Pharmaceutical to enhance transparency and professional management. The group expanded its global footprint, establishing a subsidiary in Brazil and signing an MOU in Mongolia, while Bacchus achieved record sales in Cambodia. In R&D, a New Drug Application for Tedizolid was submitted to the US FDA, and the group established Korea's first specialized dementia research center. Additionally, the group completed construction of the DM Bio Plant in Songdo to drive future growth in the biopharmaceutical market.
Company: Dong-A Socio Holdings Co Ltd
Sector: Finance & insurance
Country: South Korea
Year: 2013
Type: AR2
Pages: 116
Back to company
Dong-A Socio Holdings Co Ltd
Annual Report
The report highlights Dong-A Socio Group's transition to a holding company structure in 2013, demerging into Dong-A Socio Holdings, Dong-A ST, and Dong-A Pharmaceutical to enhance transparency and professional management. The group expanded its global footprint, establishing a subsidiary in Brazil and signing an MOU in Mongolia, while Bacchus achieved record sales in Cambodia. In R&D, a New Drug Application for Tedizolid was submitted to the US FDA, and the group established Korea's first specialized dementia research center. Additionally, the group completed construction of the DM Bio Plant in Songdo to drive future growth in the biopharmaceutical market.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Jan 1, 2013 - Dec 31, 2013
Fiscal Year
2013
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees